Maslinic acid prevents IL‐1β‐induced inflammatory response in osteoarthritis via PI3K/AKT/NF‐κB pathways
Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major rol...
Saved in:
Published in | Journal of cellular physiology Vol. 236; no. 3; pp. 1939 - 1949 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.03.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy.
Maslinic acid (MA) could prevent IL‐1β‐associated inflammation as well as extracellular matrix (ECM) degradation in human osteoarthritis (OA) chondrocytes. The potential mechanism involved in the protective effect of MA was that it could reverse inflammation‐related destruction via inhibiting PI3K/AKT/NF‐κB pathways activation. MA ameliorates OA progression in vivo via inhibiting the devastation of cartilage surface, cartilage calcification, and osteophytes formation. |
---|---|
AbstractList | Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin-1β (IL-1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL-1β-induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL-6, inducible nitric oxide synthase, cyclooxygenase-2, and tumor necrosis factor-α (TNF-α) in a concentration-dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti-inflammatory effect by inactivating the PI3K/AKT/NF-κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy.Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin-1β (IL-1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL-1β-induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL-6, inducible nitric oxide synthase, cyclooxygenase-2, and tumor necrosis factor-α (TNF-α) in a concentration-dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti-inflammatory effect by inactivating the PI3K/AKT/NF-κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy. Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy. Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor affecting the disease process. As interleukin‐1β (IL‐1β) stimulates several key mediators in the inflammatory response, it plays a major role in the pathogenesis of OA. Maslinic acid (MA) is a natural compound distributed in olive fruit. Previous studies have found that maslinic acid has an inhibitory effect on inflammation, but its specific role in the progression of OA disease has not been studied so far. In this study, we aim to assess the protective effect of MA on OA progression by in vitro and in vivo experiments. Our results indicate that, in IL‐1β‐induced inflammatory response, MA is effective in attenuating some major inflammatory mediators such as nitric oxide (NO) and prostaglandin E2, and inhibits the expression of IL‐6, inducible nitric oxide synthase, cyclooxygenase‐2, and tumor necrosis factor‐α (TNF‐α) in a concentration‐dependent manner. Also, MA downregulated the expression levels of thrombospondin motif 5 (ADAMTS5) and matrix metalloproteinase 13 in chondrocytes, resulting in reduced degradation of its extracellular matrix. Mechanistically, MA exhibits an anti‐inflammatory effect by inactivating the PI3K/AKT/NF‐κB pathway. In vivo, the protective effect of MA on OA development can be detected in a surgically induced mouse OA model. In summary, these findings suggest that MA can be used as a safe and effective potential OA therapeutic strategy. Maslinic acid (MA) could prevent IL‐1β‐associated inflammation as well as extracellular matrix (ECM) degradation in human osteoarthritis (OA) chondrocytes. The potential mechanism involved in the protective effect of MA was that it could reverse inflammation‐related destruction via inhibiting PI3K/AKT/NF‐κB pathways activation. MA ameliorates OA progression in vivo via inhibiting the devastation of cartilage surface, cartilage calcification, and osteophytes formation. |
Author | Hu, Zhi‐Chao Bao, Guo‐Dong Jin, Chen‐Qiang Hu, Xin‐Li Wu, Chen‐Yu Shen, Zhong‐Hai Ni, Wen‐Fei Yan, De‐Yi Xuan, Jiang‐Wei Bian, Yu‐Jie Chen, Yan‐Lin |
Author_xml | – sequence: 1 givenname: Yan‐Lin orcidid: 0000-0002-4274-2980 surname: Chen fullname: Chen, Yan‐Lin organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 2 givenname: De‐Yi surname: Yan fullname: Yan, De‐Yi organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 3 givenname: Chen‐Yu surname: Wu fullname: Wu, Chen‐Yu organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 4 givenname: Jiang‐Wei surname: Xuan fullname: Xuan, Jiang‐Wei organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 5 givenname: Chen‐Qiang surname: Jin fullname: Jin, Chen‐Qiang organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 6 givenname: Xin‐Li surname: Hu fullname: Hu, Xin‐Li organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 7 givenname: Guo‐Dong surname: Bao fullname: Bao, Guo‐Dong organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 8 givenname: Yu‐Jie surname: Bian fullname: Bian, Yu‐Jie organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 9 givenname: Zhi‐Chao surname: Hu fullname: Hu, Zhi‐Chao email: 764455268@qq.com organization: The Key Orthopaedic Laboratory of Zhejiang Province – sequence: 10 givenname: Zhong‐Hai surname: Shen fullname: Shen, Zhong‐Hai email: shenzhongh@163.com organization: The Second Affiliated Hospital of Jiaxing University – sequence: 11 givenname: Wen‐Fei orcidid: 0000-0001-8823-6402 surname: Ni fullname: Ni, Wen‐Fei email: wenfeini@yeah.net organization: The Key Orthopaedic Laboratory of Zhejiang Province |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32730652$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcFO3DAQhi1EVRbaAy9QWeJSDmHtOInjI10V2LIUDnC2HNsRXiV2sB3Q3voIPAtHHoKH6JPU7S4XVC4z0sz3_xrNvwu2rbMagH2MjjBC-XQph6OcMUq3wAQjRrOiKvNtMEk7nLGywDtgN4QlQogxQj6CHZJTghIzAcOFCJ2xRkIhjYKD1_faxgDni9-_HvHLU6rGqlFqBY1tO9H3Ijq_gl6Hwdmg0xS6ELUTPt56E02A90bAqzk5nx6fX09_niSHl-dvcBDx9kGswifwoRVd0J83fQ_cnHy_np1li8vT-ex4kUlSEpoJ2ihFqZRCUkVqKbHCNW2aSrUStZrVqqxU3dZ5pXFVtZIWkpVNKUua15VSiOyBr2vfwbu7UYfIexOk7jphtRsDz4s8PaxgVZnQgzfo0o3epusSRTEtCKU4UV821Nj0WvHBm174FX_9ZQKma0B6F4LXLZcmimicjV6YjmPE_6bFU1r8X1pJcfhG8Wr6P3bj_mA6vXof5D9mV2vFH4LOqEY |
CitedBy_id | crossref_primary_10_3390_ani13061041 crossref_primary_10_1016_j_phymed_2022_154347 crossref_primary_10_1080_10408398_2024_2448768 crossref_primary_10_1186_s13018_021_02528_w crossref_primary_10_1016_j_biopha_2022_114118 crossref_primary_10_2147_DDDT_S326328 crossref_primary_10_1016_j_jot_2021_05_004 crossref_primary_10_1016_j_bmc_2021_116494 crossref_primary_10_3390_molecules27248732 crossref_primary_10_3390_biomedicines13020376 crossref_primary_10_3390_foods10091993 crossref_primary_10_1186_s12938_021_00917_0 crossref_primary_10_1007_s11596_022_2657_6 crossref_primary_10_1016_j_intimp_2023_110453 crossref_primary_10_4155_fmc_2021_0127 crossref_primary_10_1016_j_intimp_2024_112435 crossref_primary_10_3389_fcvm_2021_768947 crossref_primary_10_1021_acsomega_1c06729 crossref_primary_10_3389_fphar_2021_669213 crossref_primary_10_3390_ijms22115722 crossref_primary_10_1155_2022_7000531 crossref_primary_10_3724_abbs_2024027 crossref_primary_10_1111_jocd_15730 crossref_primary_10_1186_s11658_024_00581_x crossref_primary_10_1142_S0192415X2350043X crossref_primary_10_3390_chemistry6050067 crossref_primary_10_1007_s12013_022_01083_3 crossref_primary_10_1186_s13018_023_04083_y crossref_primary_10_3389_fphar_2021_708575 crossref_primary_10_1177_19476035231181446 crossref_primary_10_1007_s13273_023_00406_6 crossref_primary_10_1016_j_clim_2021_108889 crossref_primary_10_1016_j_yexcr_2024_114172 crossref_primary_10_1039_D0BM01932A crossref_primary_10_1186_s12951_022_01598_0 crossref_primary_10_1371_journal_pone_0299351 crossref_primary_10_3389_fphar_2023_1067402 |
Cites_doi | 10.1002/ptr.5877 10.1007/s12038-018-9745-6 10.1002/jbmr.242 10.1007/s12192-018-0956-4 10.1074/jbc.M706387200 10.1016/j.ejim.2012.10.002 10.1016/j.joca.2007.07.009 10.1016/j.joca.2006.04.008 10.3390/antiox9020106 10.1016/j.joca.2010.05.025 10.1016/j.ejphar.2011.09.175 10.3390/toxins8050155 10.1002/mnfr.201200481 10.1001/jama.2013.281053 10.1007/s10753-018-0753-3 10.1021/jf101022p 10.1002/art.23176 10.1016/S0006-2952(03)00420-9 10.1016/j.joca.2014.04.018 10.1089/ten.teb.2013.0377 10.1002/art.24857 10.1007/s12272-011-0113-4 10.1007/s10195-017-0473-8 10.1371/journal.pone.0162022 10.3390/biom5031266 10.1097/BOR.0b013e328349c2b1 10.1016/j.biopha.2017.09.001 10.1039/C6FO00613B 10.1016/j.joca.2007.03.006 10.1016/S0140-6736(14)60802-3 10.1172/JCI11914 10.1055/s-2003-39698 10.1136/bmj.38159.639028.7C 10.3164/jcbn.16-119 10.1016/j.biocel.2009.09.015 10.1080/10715760500467935 10.1101/cshperspect.a000216 10.1016/j.joca.2005.07.014 10.1038/sj.onc.1203224 10.1371/journal.pone.0194572 10.1016/j.ejphar.2013.01.057 10.1016/j.semarthrit.2013.07.003 10.1016/j.biopha.2017.01.130 10.1016/S0014-5793(03)00672-0 10.1038/sj.onc.1209954 |
ContentType | Journal Article |
Copyright | 2020 Wiley Periodicals LLC 2020 Wiley Periodicals LLC. |
Copyright_xml | – notice: 2020 Wiley Periodicals LLC – notice: 2020 Wiley Periodicals LLC. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 8FD C1K FR3 K9. P64 RC3 7X8 |
DOI | 10.1002/jcp.29977 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Technology Research Database Toxicology Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Genetics Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Biology |
EISSN | 1097-4652 |
EndPage | 1949 |
ExternalDocumentID | 32730652 10_1002_jcp_29977 JCP29977 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Zhejiang Provincial Natural Science Foundation of China funderid: LY17H060009 – fundername: Wenzhou Municipal Science and Technology Bureau funderid: Y20190078 – fundername: Clinical Scientific Research Project of the Second Affiliated Hospital of the Wenzhou Medical University funderid: SAHoWMU‐CR2017‐08‐106 |
GroupedDBID | --- -DZ -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 9M8 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDPE ABEFU ABEML ABIJN ABJNI ABPPZ ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACNCT ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AUFTA AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BQCPF BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ H~9 IH2 IX1 J0M JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M56 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NEJ NF~ NNB O66 O9- OHT OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RWR RX1 RYL S10 SAMSI SUPJJ SV3 TN5 TWZ UB1 UPT V2E V8K VQP W8V W99 WBKPD WH7 WIB WIH WIK WJL WNSPC WOHZO WQJ WRC WXSBR WYB WYISQ X7M XG1 XJT XOL XPP XSW XV2 Y6R YQT YZZ ZGI ZXP ZZTAW ~IA ~WT AAYXX ADXHL AETEA AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7TK 7U7 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY C1K FR3 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3537-a7bdd77ccac7d38cc1d187bb6dfc0fe98d56d8f826e166fc74c95b5c57286dd03 |
IEDL.DBID | DR2 |
ISSN | 0021-9541 1097-4652 |
IngestDate | Thu Jul 10 17:36:15 EDT 2025 Sat Jul 26 00:47:49 EDT 2025 Thu Apr 03 07:06:46 EDT 2025 Tue Jul 01 03:23:42 EDT 2025 Thu Apr 24 22:55:15 EDT 2025 Wed Jan 22 16:31:35 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | PI3K/Akt/NF-κB osteoarthritis maslinic acid |
Language | English |
License | 2020 Wiley Periodicals LLC. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3537-a7bdd77ccac7d38cc1d187bb6dfc0fe98d56d8f826e166fc74c95b5c57286dd03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4274-2980 0000-0001-8823-6402 |
PMID | 32730652 |
PQID | 2471743771 |
PQPubID | 1006363 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_2429774965 proquest_journals_2471743771 pubmed_primary_32730652 crossref_citationtrail_10_1002_jcp_29977 crossref_primary_10_1002_jcp_29977 wiley_primary_10_1002_jcp_29977_JCP29977 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | March 2021 2021-03-00 20210301 |
PublicationDateYYYYMMDD | 2021-03-01 |
PublicationDate_xml | – month: 03 year: 2021 text: March 2021 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cellular physiology |
PublicationTitleAlternate | J Cell Physiol |
PublicationYear | 2021 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2017; 61 2015; 5 2010; 58 2013; 708 2013; 43 2010; 18 2013; 24 2009; 60 2015; 386 2006; 14 2017; 89 2008; 58 2014; 24 2018; 41 2011; 34 2004; 329 2001; 107 2018; 43 2014; 22 2011; 672 2008; 283 2007; 15 2014; 20 2016; 11 2017; 95 2017; 31 2016; 7 2010; 42 2003; 547 2006; 40 1991; 26 2013; 57 1999; 18 2019; 24 2006; 25 2020; 9 2013; 310 2003; 69 2011; 23 2017; 18 2011; 26 2010; 2 2018; 16 2016; 8 2003; 66 2018; 13 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_25_1 e_1_2_8_46_1 e_1_2_8_27_1 e_1_2_8_48_1 Zou Z. M. (e_1_2_8_49_1) 1991; 26 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 Gross J. B. (e_1_2_8_15_1) 2014; 24 Li H. (e_1_2_8_26_1) 2018; 16 e_1_2_8_30_1 |
References_xml | – volume: 60 start-page: 2985 issue: 10 year: 2009 end-page: 2996 article-title: Mechanical injury potentiates proteoglycan catabolism induced by interleukin‐6 with soluble interleukin‐6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage publication-title: Arthtitis and Rheumatism – volume: 2 issue: 1 year: 2010 article-title: The regulatory logic of the NF‐kappaB signaling system publication-title: Cold Spring Harbor Perspectives in Biology – volume: 708 start-page: 1 issue: 1‐3 year: 2013 end-page: 7 article-title: Celastrol, an inhibitor of heat shock protein 90beta potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase‐2 in primary human osteoarthritic chondrocytes publication-title: European Journal of Pharmacology – volume: 26 start-page: 644 issue: 3 year: 2011 end-page: 656 article-title: Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy‐induced bone loss by regulating RANKL‐mediated NF‐kappaB and MAPK signaling pathways publication-title: Journal of Bone and Mineral Research – volume: 25 start-page: 6680 issue: 51 year: 2006 end-page: 6684 article-title: Introduction to NF‐kappaB: Players, pathways, perspectives publication-title: Oncogene – volume: 24 start-page: 11 issue: 1 year: 2013 end-page: 15 article-title: Serological markers of erosive hand osteoarthritis publication-title: European Journal of Internal Medicine – volume: 41 start-page: 996 issue: 3 year: 2018 end-page: 1007 article-title: Nobiletin‐ameliorated lipopolysaccharide‐induced inflammation in acute lung injury by suppression of NF‐kappaB pathway in vivo and vitro publication-title: Inflammation – volume: 18 start-page: 349 issue: 4 year: 2017 end-page: 357 article-title: Circulating levels of proinflammatory mediators as potential biomarkers of post‐traumatic knee osteoarthritis development publication-title: Journal of Orthopaedics and Traumatology – volume: 16 start-page: 4737 issue: 6 year: 2018 end-page: 4744 article-title: TNF‐alpha increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate‐induced osteoarthritis publication-title: Experimental and Therapeutic Medicine – volume: 24 start-page: 195 issue: 1 year: 2019 end-page: 202 article-title: PI3K/Akt and caspase pathways mediate oxidative stress‐induced chondrocyte apoptosis publication-title: Cell Stress and Chaperones – volume: 107 start-page: 135 issue: 2 year: 2001 end-page: 142 article-title: Therapeutic potential of inhibition of the NF‐kappaB pathway in the treatment of inflammation and cancer publication-title: Journal of Clinical Investigation – volume: 7 start-page: 2870 issue: 6 year: 2016 end-page: 2877 article-title: Chemical characterization of the main bioactive constituents from fruits of publication-title: Food & Function – volume: 13 issue: 3 year: 2018 article-title: Evaluation of maslinic acid with whole‐body vibration training in elderly women with knee osteoarthritis publication-title: PLOS One – volume: 43 start-page: 303 issue: 3 year: 2013 end-page: 313 article-title: Health economics in the field of osteoarthritis: An expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) publication-title: Seminars in Arthritis and Rheumatism – volume: 15 start-page: 1061 issue: 9 year: 2007 end-page: 1069 article-title: The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse publication-title: Osteoarthritis and Cartilage – volume: 42 start-page: 198 issue: 2 year: 2010 end-page: 201 article-title: Prostaglandin E2 at new glance: Novel insights in functional diversity offer therapeutic chances publication-title: International Journal of Biochemistry and Cell Biology – volume: 34 start-page: 109 issue: 1 year: 2011 end-page: 117 article-title: Matrix metalloproteinase‐13 expression in IL‐1beta‐treated chondrocytes by activation of the p38 MAPK/c‐Fos/AP‐1 and JAK/STAT pathways publication-title: Archives of Pharmacal Research – volume: 9 issue: 2 year: 2020 article-title: Maslinic acid ameliorates inflammation via the downregulation of NF‐kappaB and STAT‐1 publication-title: Antioxidants – volume: 547 start-page: 75 issue: 1–3 year: 2003 end-page: 79 article-title: IL‐1beta‐dependent activation of NF‐kappaB mediates PGE2 release via the expression of cyclooxygenase‐2 and microsomal prostaglandin E synthase publication-title: FEBS Letters – volume: 69 start-page: 472 issue: 5 year: 2003 end-page: 474 article-title: Antioxidant activity of maslinic acid, a triterpene derivative obtained from publication-title: Planta Medica – volume: 89 start-page: 1252 year: 2017 end-page: 1261 article-title: Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis publication-title: Biomedicine & Pharmacotherapy – volume: 95 start-page: 904 year: 2017 end-page: 913 article-title: Maslinic acid inhibits impairment of endothelial functions induced by high glucose in HAEC cells through improving insulin signaling and oxidative stress publication-title: Biomedicine & Pharmacotherapy – volume: 18 start-page: S17 issue: Suppl. 3 year: 2010 end-page: S23 article-title: The OARSI histopathology initiative—Recommendations for histological assessments of osteoarthritis in the mouse publication-title: Osteoarthritis and Cartilage – volume: 14 start-page: 13 issue: 1 year: 2006 end-page: 29 article-title: Osteoarthritis cartilage histopathology: Grading and staging publication-title: Osteoarthritis and Cartilage – volume: 57 start-page: 339 issue: 2 year: 2013 end-page: 346 article-title: Assessment of the safety of maslinic acid, a bioactive compound from L publication-title: Molecular Nutrition & Food Research – volume: 8 issue: 5 year: 2016 article-title: ADAM and ADAMTS family proteins and snake venom metalloproteinases: A structural overview publication-title: Toxins – volume: 26 start-page: 906 issue: 12 year: 1991 end-page: 910 article-title: Studies on the chemical constituents from roots of publication-title: Yao Xue Xue Bao – volume: 329 start-page: 324 issue: 7461 year: 2004 article-title: Efficacy of topical non‐steroidal anti‐inflammatory drugs in the treatment of osteoarthritis: Meta‐analysis of randomised controlled trials publication-title: BMJ – volume: 43 start-page: 277 issue: 2 year: 2018 end-page: 285 article-title: Maslinic acid modulates secreted phospholipase A2‐IIA (sPLA2‐IIA)‐mediated inflammatory effects in macrophage foam cells formation publication-title: Journal of Biosciences – volume: 61 start-page: 67 issue: 1 year: 2017 end-page: 73 article-title: Maslinic acid improves quality of life by alleviating joint knee pain in the elderly: Results from a community‐based pilot study publication-title: Journal of Clinical Biochemistry and Nutrition – volume: 310 start-page: 2191 issue: 20 year: 2013 end-page: 2194 article-title: World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects publication-title: Journal of the American Medical Association – volume: 58 start-page: 26 issue: 1 year: 2008 end-page: 35 article-title: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II publication-title: Arthtitis and Rheumatism – volume: 14 start-page: 839 issue: 9 year: 2006 end-page: 848 article-title: NF‐kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis publication-title: Osteoarthritis and Cartilage – volume: 22 start-page: 933 issue: 7 year: 2014 end-page: 940 article-title: Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast‐enhanced magnetic resonance imaging in obese patients with osteoarthritis: A cross‐sectional study publication-title: Osteoarthritis and Cartilage – volume: 18 start-page: 6845 issue: 49 year: 1999 end-page: 6852 article-title: Regulation of DNA binding by Rel/NF‐kappaB transcription factors: Structural views publication-title: Oncogene – volume: 11 issue: 9 year: 2016 article-title: Shea nut oil triterpene concentrate attenuates knee osteoarthritis development in rats: Evidence from knee joint histology publication-title: PLOS One – volume: 31 start-page: 1457 issue: 9 year: 2017 end-page: 1460 article-title: Bioactive triterpenes from the root of salvia miltiorrhiza bunge publication-title: Phytotherapy Research – volume: 5 start-page: 1266 issue: 3 year: 2015 end-page: 1283 article-title: NF‐kappaB signaling in chronic inflammatory airway disease publication-title: Biomolecules – volume: 40 start-page: 295 issue: 3 year: 2006 end-page: 302 article-title: Supressive effect of maslinic acid from pomace olive oil on oxidative stress and cytokine production in stimulated murine macrophages publication-title: Free Radical Research – volume: 386 start-page: 376 issue: 9991 year: 2015 end-page: 387 article-title: Osteoarthritis publication-title: Lancet – volume: 24 start-page: 17 issue: 1 Suppl. year: 2014 end-page: 25 article-title: Synovial fluid levels of adipokines in osteoarthritis: Association with local factors of inflammation and cartilage maintenance publication-title: Biomedical Materials and Engineering – volume: 23 start-page: 471 issue: 5 year: 2011 end-page: 478 article-title: Inflammation in osteoarthritis publication-title: Current Opinion in Rheumatology – volume: 283 start-page: 4850 issue: 8 year: 2008 end-page: 4865 article-title: Interleukin‐6 (IL‐6) and/or soluble IL‐6 receptor down‐regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter publication-title: Journal of Biological Chemistry – volume: 672 start-page: 169 issue: 1‐3 year: 2011 end-page: 174 article-title: Anti‐inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor‐kappa B publication-title: European Journal of Pharmacology – volume: 20 start-page: 355 issue: 4 year: 2014 end-page: 363 article-title: The roles of catabolic factors in the development of osteoarthritis publication-title: Tissue Engineering. Part B, Reviews – volume: 58 start-page: 6285 issue: 10 year: 2010 end-page: 6289 article-title: Characterization of triterpenic acids in fruits of ziziphus species by HPLC‐ELSD‐MS publication-title: Journal of Agricultural and Food Chemistry – volume: 66 start-page: 1055 issue: 6 year: 2003 end-page: 1060 article-title: Role of cyclooxygenase‐2, but not cyclooxygenase‐1, on type II collagen‐induced arthritis in DBA/1J mice publication-title: Biochemical Pharmacology – volume: 15 start-page: 1249 issue: 11 year: 2007 end-page: 1255 article-title: Avocado soybean unsaponifiables (ASU) suppress TNF‐alpha, IL‐1beta, COX‐2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages publication-title: Osteoarthritis and Cartilage – ident: e_1_2_8_43_1 doi: 10.1002/ptr.5877 – ident: e_1_2_8_47_1 doi: 10.1007/s12038-018-9745-6 – ident: e_1_2_8_23_1 doi: 10.1002/jbmr.242 – ident: e_1_2_8_24_1 doi: 10.1007/s12192-018-0956-4 – ident: e_1_2_8_35_1 doi: 10.1074/jbc.M706387200 – ident: e_1_2_8_37_1 doi: 10.1016/j.ejim.2012.10.002 – ident: e_1_2_8_2_1 doi: 10.1016/j.joca.2007.07.009 – ident: e_1_2_8_38_1 doi: 10.1016/j.joca.2006.04.008 – ident: e_1_2_8_21_1 doi: 10.3390/antiox9020106 – ident: e_1_2_8_12_1 doi: 10.1016/j.joca.2010.05.025 – ident: e_1_2_8_18_1 doi: 10.1016/j.ejphar.2011.09.175 – ident: e_1_2_8_42_1 doi: 10.3390/toxins8050155 – ident: e_1_2_8_39_1 doi: 10.1002/mnfr.201200481 – ident: e_1_2_8_44_1 doi: 10.1001/jama.2013.281053 – ident: e_1_2_8_27_1 doi: 10.1007/s10753-018-0753-3 – ident: e_1_2_8_16_1 doi: 10.1021/jf101022p – ident: e_1_2_8_20_1 doi: 10.1002/art.23176 – ident: e_1_2_8_33_1 doi: 10.1016/S0006-2952(03)00420-9 – ident: e_1_2_8_4_1 doi: 10.1016/j.joca.2014.04.018 – ident: e_1_2_8_5_1 doi: 10.1089/ten.teb.2013.0377 – ident: e_1_2_8_41_1 doi: 10.1002/art.24857 – ident: e_1_2_8_28_1 doi: 10.1007/s12272-011-0113-4 – ident: e_1_2_8_34_1 doi: 10.1007/s10195-017-0473-8 – ident: e_1_2_8_19_1 doi: 10.1371/journal.pone.0162022 – ident: e_1_2_8_40_1 doi: 10.3390/biom5031266 – ident: e_1_2_8_14_1 doi: 10.1097/BOR.0b013e328349c2b1 – ident: e_1_2_8_25_1 doi: 10.1016/j.biopha.2017.09.001 – ident: e_1_2_8_3_1 doi: 10.1039/C6FO00613B – ident: e_1_2_8_11_1 doi: 10.1016/j.joca.2007.03.006 – ident: e_1_2_8_13_1 doi: 10.1016/S0140-6736(14)60802-3 – ident: e_1_2_8_46_1 doi: 10.1172/JCI11914 – ident: e_1_2_8_31_1 doi: 10.1055/s-2003-39698 – ident: e_1_2_8_29_1 doi: 10.1136/bmj.38159.639028.7C – ident: e_1_2_8_9_1 doi: 10.3164/jcbn.16-119 – ident: e_1_2_8_22_1 doi: 10.1016/j.biocel.2009.09.015 – ident: e_1_2_8_30_1 doi: 10.1080/10715760500467935 – ident: e_1_2_8_32_1 doi: 10.1101/cshperspect.a000216 – ident: e_1_2_8_36_1 doi: 10.1016/j.joca.2005.07.014 – volume: 16 start-page: 4737 issue: 6 year: 2018 ident: e_1_2_8_26_1 article-title: TNF‐alpha increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K/AKT pathway in a rat model of monosodium iodoacetate‐induced osteoarthritis publication-title: Experimental and Therapeutic Medicine – volume: 26 start-page: 906 issue: 12 year: 1991 ident: e_1_2_8_49_1 article-title: Studies on the chemical constituents from roots of Agastache rugosa publication-title: Yao Xue Xue Bao – ident: e_1_2_8_7_1 doi: 10.1038/sj.onc.1203224 – ident: e_1_2_8_48_1 doi: 10.1371/journal.pone.0194572 – ident: e_1_2_8_8_1 doi: 10.1016/j.ejphar.2013.01.057 – ident: e_1_2_8_17_1 doi: 10.1016/j.semarthrit.2013.07.003 – ident: e_1_2_8_45_1 doi: 10.1016/j.biopha.2017.01.130 – volume: 24 start-page: 17 issue: 1 year: 2014 ident: e_1_2_8_15_1 article-title: Synovial fluid levels of adipokines in osteoarthritis: Association with local factors of inflammation and cartilage maintenance publication-title: Biomedical Materials and Engineering – ident: e_1_2_8_6_1 doi: 10.1016/S0014-5793(03)00672-0 – ident: e_1_2_8_10_1 doi: 10.1038/sj.onc.1209954 |
SSID | ssj0009933 |
Score | 2.506911 |
Snippet | Osteoarthritis (OA) is a degenerative joint disease characterized by destruction of articular cartilage. The inflammatory response is the most important factor... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1939 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase Aged AKT protein Animals Arthritis Biomedical materials Cartilage Cartilage (articular) Cartilage diseases Cell Survival - drug effects Chondrocytes Chondrocytes - drug effects Chondrocytes - metabolism Chondrocytes - pathology Collagenase 3 Cyclooxygenase 2 - metabolism Dinoprostone - metabolism Disease Models, Animal Extracellular matrix Extracellular Matrix - drug effects Extracellular Matrix - metabolism Female Humans Inflammation Inflammation - complications Inflammation - prevention & control Inflammatory response Interleukin-1beta - adverse effects Interleukin-6 - metabolism Interleukins Joint diseases Male maslinic acid Matrix metalloproteinase Matrix metalloproteinases Mice Mice, Inbred C57BL Models, Biological NF-kappa B - metabolism NF-KappaB Inhibitor alpha - metabolism Nitric oxide Nitric Oxide - metabolism Nitric Oxide Synthase Type II - metabolism Nitric-oxide synthase Osteoarthritis Osteoarthritis - drug therapy Osteoarthritis - metabolism Pathogenesis Phosphatidylinositol 3-Kinases - metabolism PI3K/Akt/NF‐κB Prostaglandin E2 Prostaglandin endoperoxide synthase Protein Transport - drug effects Proteolysis - drug effects Proto-Oncogene Proteins c-akt - metabolism Signal Transduction Thrombospondin Transcription Factor RelA - metabolism Triterpenes - chemistry Triterpenes - pharmacology Triterpenes - therapeutic use Tumor necrosis factor Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF |
Title | Maslinic acid prevents IL‐1β‐induced inflammatory response in osteoarthritis via PI3K/AKT/NF‐κB pathways |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.29977 https://www.ncbi.nlm.nih.gov/pubmed/32730652 https://www.proquest.com/docview/2471743771 https://www.proquest.com/docview/2429774965 |
Volume | 236 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2qKiGx4dHyGCjIIITYZCZ24jgRq1IxagutKkSlLpAiP0WBZkbNDNV0xSfwLSz5iH5Ev6TXzqMqDwmxiaLEiRPnXPvYufdcgGdGuNgJriITKxulKRORUlpF2mVFomkq87DesbObbe6n2wf8YAledrEwjT5Ev-DmLSP0197ApapHl6Khn_R0iH2p8JHk3lfLE6J3l9JRRZtGPrgg8JR2qkIxG_VXXh2LfiOYV_lqGHDGN-FD96iNn8nn4Xymhvr0FxXH_3yXW3CjJaJkvUHObViy1Qqsrlc4CT9akOckuIaGNfcVuNZkrFyswnRH1iGWkkh9aMi0EYCqydbb82_f6dkP3OIkH-FiCEIX0XYU_uKT48YV1-JR4sNKJojYj0FPiXw9lGRvK3kzQro52h3jHc5-viI-U_KJXNR3YH_8-v3GZtQmbYh0whMRSaGMEQKBoYVJcq2poblQKjNOx84WueGZyR3OaizNfKBRqguuuOaC5ZkxcXIXlqtJZe8D0cxSbaxjVto0py5HaqOl0JlylMVGDeBF9_lK3Sqa-8QaX8pGi5mV2K5laNcBPO2LThsZjz8VWuswULaWXJcMR29kWULQATzpT6MN-h8rsrKTuS_DPI0uMj6Aew12-loS5IdI8xg-bEDA36svtzf2ws6Dfy_6EK4zj_DgFLcGy7PjuX2ELGmmHgdzuABFAhPI |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qRQg2PFoeUwoYhBCbzMTOw4nUTSmMZtqZUYVaqRsU-RW1hWZGnZmiYcUn8C1d8hH9CL6Ea-dRlYeE2ERR4sSOc659bF-fC_BS89zPeSQ97UvjhSHjnpRKeiqP00DRUCRuvmM4inv74fZBdLAEG_VemFIfoplws5bh2mtr4HZCunOpGnqsJm1sTDm_BtdtRG-rnP_2_aV4VFoFkndOCFFIa10hn3WaR6_2Rr9RzKuM1XU53TvwoS5s6WnysT2fybb68ouO4_9-zV24XXFRslmC5x4smWIFVjcLHIefLMgr4rxD3bT7Ctwog1YuVmEyFFO3nZIIdaTJpNSAmpL-4MfXb_TiHI84zkfEaILoRcCduIV8clp64xq8SuzOkjGC9tBJKpGzI0F2-8FOBxlnZ9TFN1x8f0NssOTPYjG9D_vdd3tbPa-K2-CpIAq4J7jUmnPEhuI6SJSimiZcyljnys9Nmugo1kmOAxtDY7vXKFRpJCMVcZbEWvvBA1guxoV5BEQxQ5U2OTPChAnNE2Q3SnAVy5wyX8sWvK7_X6YqUXMbW-NTVsoxswzrNXP12oIXTdJJqeTxp0TrNQiyypinGcMOHIkW57QFz5vbaIZ2bUUUZjy3aZhl0mkcteBhCZ4mlwApIjI9hoV1EPh79tn21q47Wfv3pM_gZm9vOMgG_dHOY7jFLNydj9w6LM9O5-YJkqaZfOps4ydchBfk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ZbtQwFL0qRSBeWFqWKQUMQoiXzMTO4kR9Ki2jTpfRCFGpD0hRvKktNBN1ZoqGJz6Bb-kjH9GP4Eu4dpaqLBLiJYoSJ3acc-1j-_pcgJeKG9_wSHjKF9oLQ8Y9IaTwpInTQNIwT9x8x94w3toPtw-igwVYa_bCVPoQ7YSbtQzXXlsDL5XpXYqGHsuyi20p59fgehj7qY3bsPnuUjsqrePIOx-EKKSNrJDPeu2jVzuj3xjmVcLqepz-HfjQlLVyNPnYnU1FV375RcbxPz_mLtyumShZr6BzDxZ0sQTL6wWOwk_m5BVxvqFu0n0JblQhK-fLUO7lE7eZkuTySJGyUoCakMHuj6_f6MU5HnGUj3hRBLGLcDtxy_jktPLF1XiV2H0lY4TsoRNUImdHORkNgp0e8s3esI9vuPj-hthQyZ_z-eQ-7Pffvt_Y8uqoDZ4MooB7ORdKcY7IkFwFiZRU0YQLESsjfaPTREWxSgwOazSN7U6jUKaRiGTEWRIr5QcPYLEYF_oREMk0lUobpnMdJtQkyG1kzmUsDGW-Eh143fy-TNaS5jayxqesEmNmGdZr5uq1Ay_apGWl4_GnRKsNBrLalCcZw-4baRbntAPP29tohHZlJS_0eGbTMMuj0zjqwMMKO20uARJE5HkMC-sQ8Pfss-2NkTtZ-fekz-DmaLOf7Q6GO4_hFrNgdw5yq7A4PZ3pJ8iYpuKps4yfFrMWkw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Maslinic+acid+prevents+IL%E2%80%901%CE%B2%E2%80%90induced+inflammatory+response+in+osteoarthritis+via+PI3K%2FAKT%2FNF%E2%80%90%CE%BAB+pathways&rft.jtitle=Journal+of+cellular+physiology&rft.au=Chen%2C+Yan%E2%80%90Lin&rft.au=Yan%2C+De%E2%80%90Yi&rft.au=Wu%2C+Chen%E2%80%90Yu&rft.au=Xuan%2C+Jiang%E2%80%90Wei&rft.date=2021-03-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=236&rft.issue=3&rft.spage=1939&rft.epage=1949&rft_id=info:doi/10.1002%2Fjcp.29977&rft.externalDBID=10.1002%252Fjcp.29977&rft.externalDocID=JCP29977 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon |